Biotron (Biotron) Cash Payments : $-1.87 Mil (TTM As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Biotron Cash Payments?

Biotron's Cash Payments for the six months ended in Dec. 2023 was $-2.22 Mil.

Biotron's Cash Payments for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.87 Mil.

Biotron Cash Payments Historical Data

The historical data trend for Biotron's Cash Payments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotron Cash Payments Chart

Biotron Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash Payments

Get a 7-Day Free Trial

-1.10

-0.98

-1.06

-0.97

-1.19

Biotron Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash Payments	Get a 7-Day Free Trial															-1.32	0.33	-1.54	0.35	-2.22

Biotron Cash Payments Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Payments represents cash flow paid from operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Payments" section for non-financial companies:
Payments to Suppliers for Goods and Services
Payments on Behalf of Employees
Other Cash Payments from Operating Activities

Cash Payments for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.87 Mil.

Biotron Cash Payments Related Terms

Thank you for viewing the detailed overview of Biotron's Cash Payments provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotron (Biotron) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (OTCPK:BITRF) » Definitions » Cash Payments

Comparable Companies

Traded in Other Exchanges

BIT:Australia

Address

56 Delhi Road, Suite 3.3, North Ryde, Sydney, NSW, AUS, 2113

Website

https://www.biotron.com.au

Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Biotron (Biotron) Headlines

From GuruFocus

Biotron Drug Effective Against COVID-19 In Animals

By PRNewswire PRNewswire • 11-25-2021